Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

The World Health Organization (WHO) has released a detailed plan that seeks $31.3 billion in funding to support the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration launched by the WHO and others to accelerate the development,...

Advanced Accelerator Applications (AAA), a Novartis company, has executed a sales and purchase agreement for a 50,000-square-foot piece of land in Indianapolis, Indiana to build a radioligand therapy manufacturing plant. The facility will expand...

The US Food and Drug Administration has issued final guidance that provides recommendations to pharmaceutical manufacturers on actions to take when an employee who has been directly involved in manufacturing drugs has a confirmed infection of...

Bayer has agreed to pay between $10.1 billion and $10.9 billion to resolve current and future product-liability litigation in the US over its glyphosate-based herbicide, Roundup, which the company acquired in its $63-billion acquisition of the...

Merck & Co. has completed its previously announced acquisition of Themis Bioscience, a Vienna, Austria-based biopharmaceutical company developing vaccines and immune-modulation therapies for infectious diseases and cancer. With the completion...

The latest on manufacturing and potential treatments for COVID-19 with news from Novartis, the National Institutes of Health, Gilead, GSK, Congress, Inovio, and Cipla. News from Novartis, NIH, Gilead, GSK, Congress Novartis Discontinues Trial of...